ADC Therapeutics ADCT
NYSE ADCT
$1.07 -0.15 (-12.30%)
As of: Oct 1, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Return on Equity [ROE] (2021 - 2023)

Updated

ADC Therapeutics' Return on Equity [ROE] was -4155.58% in Q2 2023, down 4021.08 percentage points from -134.50% a year earlier and down 3787.44 percentage points from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Return on Equity [ROE] (2021 - 2023) Analysis & Trends

For FY2022, Return on Equity [ROE] at ADC Therapeutics came in at -133.46%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 ADC Therapeutics 152.93 Mn -793.27 Mn 16.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -4,155.58%
Mar 31, 2023 -368.15%
Jun 30, 2022 -134.50%
Mar 31, 2022 -123.25%
Jun 30, 2021 -73.95%
API Access

ADC Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY